D
Sarepta Therapeutics, Inc. SRPT
$20.22 $0.160.80% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 64.89% 59.15% 52.97% 48.45% 49.98%
Total Other Revenue -- -- -- -- --
Total Revenue 64.89% 59.15% 52.97% 48.45% 49.98%
Cost of Revenue 102.53% 78.73% 9.33% -0.15% -10.56%
Gross Profit 1.14% 10.95% 261.01% 742.24% 1,124.58%
SG&A Expenses 8.72% 13.32% 15.77% 11.70% 14.05%
Depreciation & Amortization 2.79% 21.34% 54.27% 163.28% 236.69%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 69.22% 56.90% 11.43% 3.66% -3.05%
Operating Income -102.45% -23.60% 181.43% 120.29% 107.45%
Income Before Tax -138.78% -582.07% 150.14% 119.55% 107.03%
Income Tax Expenses 126.63% 390.57% 60.81% -74.03% -34.13%
Earnings from Continuing Operations -222.54% -1,570.01% 143.89% 117.64% 105.21%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -222.54% -1,570.01% 143.89% 117.64% 105.21%
EBIT -102.45% -23.60% 181.43% 120.29% 107.45%
EBITDA -48.36% -47.66% 214.49% 133.64% 116.67%
EPS Basic -221.51% -1,881.02% 140.26% 116.50% 104.65%
Normalized Basic EPS -86.13% -13.41% 182.05% 122.05% 109.51%
EPS Diluted -271.86% -2,553.33% 138.99% 115.86% 104.30%
Normalized Diluted EPS -142.62% -30.65% 173.95% 121.04% 108.94%
Average Basic Shares Outstanding 4.29% 5.04% 5.80% 6.77% 5.31%
Average Diluted Shares Outstanding 7.45% 8.44% 12.18% 11.93% 9.05%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --